These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 24566461

  • 21. Migraines with and without aura and their response to preventive therapy with topiramate.
    Reuter U, Sanchez Del Rio M, Diener HC, Allais G, Davies B, Gendolla A, Pfeil J, Schwalen S, Schäuble B, van Oene J.
    Cephalalgia; 2010 May; 30(5):543-51. PubMed ID: 19732072
    [Abstract] [Full Text] [Related]

  • 22. Topiramate in the prevention of pediatric migraine: literature review.
    Ferraro D, Di Trapani G.
    J Headache Pain; 2008 Jun; 9(3):147-50. PubMed ID: 18385933
    [Abstract] [Full Text] [Related]

  • 23. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 24. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD.
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [Abstract] [Full Text] [Related]

  • 25. Topiramate: new indication. Migraine prevention: best avoided.
    Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
    [Abstract] [Full Text] [Related]

  • 26. Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.
    Freitag FG, Forde G, Neto W, Wang DZ, Schmitt J, Wu SC, Hulihan J.
    J Am Osteopath Assoc; 2007 Jul; 107(7):251-8. PubMed ID: 17682112
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness of topiramate in the prevention of childhood headaches.
    Hershey AD, Powers SW, Vockell AL, LeCates S, Kabbouche M.
    Headache; 2002 Sep; 42(8):810-8. PubMed ID: 12390646
    [Abstract] [Full Text] [Related]

  • 28. Topiramate for migraine prophylaxis among Chinese population.
    Li HL, Kwan P, Leung H, Yu E, Tsoi TH, Hui AC, Sheng B, Lau KK.
    Headache; 2007 Apr; 47(4):616-9. PubMed ID: 17445114
    [Abstract] [Full Text] [Related]

  • 29. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 30. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 31. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
    Storey JR, Calder CS, Hart DE, Potter DL.
    Headache; 2001 Apr; 41(10):968-75. PubMed ID: 11903524
    [Abstract] [Full Text] [Related]

  • 32. Migraine headache prophylaxis in adolescents.
    Fantasia HC.
    Nurs Womens Health; 2014 Apr; 18(5):420-4. PubMed ID: 25316542
    [Abstract] [Full Text] [Related]

  • 33. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [Abstract] [Full Text] [Related]

  • 34. Is topiramate effective for migraine prevention in patients less than 18 years of age? A meta-analysis of randomized controlled trials.
    Le K, Yu D, Wang J, Ali AI, Guo Y.
    J Headache Pain; 2017 Dec; 18(1):69. PubMed ID: 28721545
    [Abstract] [Full Text] [Related]

  • 35. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
    Mei D, Capuano A, Vollono C, Evangelista M, Ferraro D, Tonali P, Di Trapani G.
    Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081
    [Abstract] [Full Text] [Related]

  • 36. Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine.
    Hershey AD, Powers SW, Coffey CS, Eklund DD, Chamberlin LA, Korbee LL, CHAMP Study Group.
    Headache; 2013 May; 53(5):799-816. PubMed ID: 23594025
    [Abstract] [Full Text] [Related]

  • 37. Topiramate for migraine prevention.
    Wenzel RG, Schwarz K, Padiyara RS.
    Pharmacotherapy; 2006 Mar; 26(3):375-87. PubMed ID: 16503717
    [Abstract] [Full Text] [Related]

  • 38. Comparison of efficacy and safety of topiramate with gabapentin in migraine prophylaxis: randomized open label control trial.
    Zain S, Khan M, Alam R, Zafar I, Ahmed S.
    J Pak Med Assoc; 2013 Jan; 63(1):3-7. PubMed ID: 23865122
    [Abstract] [Full Text] [Related]

  • 39. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
    Cady RK, Schreiber CP, Porter JA, Blumenfeld AM, Farmer KU.
    Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
    [Abstract] [Full Text] [Related]

  • 40. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE, Abbasi V, Sajedi SA, Majdinasab N, Abdollahi F, Hajmanouchehri R, Faraji A.
    Clin Neuropharmacol; 2011 Jan; 34(4):174-7. PubMed ID: 21738025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.